Answers are grounded in this paper and cite their sources.
Our previous studies reported that L-Cysteine-derived H2S had remarkably neuroprotective effects against hypoxia-ischemic (HI) insult in neonatal animals. Here, we assessed one of the mechanisms of protection exerted by L-Cysteine which stimulate microglial polarization to the M2 phenotype and modulating complement expression after neonatal HI. L-Cysteine treatment suppressed the production of inflammatory markers, while dramatically up-regulated levels of anti-inflammatory cytokines in the damaged cortex. L-Cysteine administration promoted the conversion of microglia phenotype from inflammatory M1 to anti-inflammatory M2, associated with inhibiting p38 and/or JNK proinflammatory pathway and nuclear factor-κB activation. Furthermore, L-Cysteine decreased the HI-derived levels of complement proteins C1q, C3a and C3a receptor. Noting, blockade of H2S-producing clearly prevented L-Cysteine-mediated M2 polarization and complement expression. L-Cysteine significantly inhibited the neuronal apoptosis induced by the conditioned medium from activated M1 microglia in vitro. L-Cysteine treatment promoted AMPK activation and AMPK inhibitor abolished the anti-apoptotic and anti-inflammatory effects of L-Cysteine described above. Taken together, our findings suggested that L-Cysteine-derived H2S attenuated neuronal apoptosis after HI at least in part by enhancing microglia M2 polarization and modulating complement expression via AMPK activation.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: